A Study of Alternate Biomarkers in HIV Disease and Evaluating their Efficacy in Predicting T CD4+ Cell Counts and Disease Progression in Resource Poor Settings in Highly Active Antiretroviral Therapy (HAART) Era
Introduction: Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has been a challenge to medical fraternity since it was first discovered in 1983. About 40 million people are living with HIV infection globally and 99% of the infected people are in south East Asia (SEA). Traditional...
Main Authors: | K V Ramana, V Sabitha, Ratna Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2013-07-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/3138/17%20-%205306_PF1(M)_E(C)_F(T)_PF1(PUH)_PFA(H)_1.pdf |
Similar Items
-
Ocular problems in brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era
by: Marcia Lopes Rodrigues, et al. -
Prevalence of tuberculosis in HIV in Ethiopia in early HAART era: retrospective analysis
by: Esayas Kebede Gudina, et al.
Published: (2013-04-01) -
Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al. -
Association of oral candidal carriage, candidal density and CD4 count among normal, HIV patients with HAART and without HAART
by: Shahabe Saquib Abullais, et al.
Published: (2022-06-01) -
Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
by: Hamilton Domingos, et al.